 REDWOOD CITY, Calif., Aug. 03, 2021 GLOBE NEWSWIRE -- Pulmonx Corporation Nasdaq: LUNG Pulmonx or the Company, a global leader in minimally invasive treatments for severe lung disease, today reported financial results for the second quarter ended June 30, 2021. 